Bariatric Surgery - We have a renewed focus on bringing greater precision to every aspect of Bariatric Surgery. From providing training, research and innovative products, we are enabling better outcomes in Bariatric Surgery.

Gynecologic Surgery - Our goal is to partner with the gynecologic community to ensure positive clinical outcomes. We offer solutions to support a number of gynecological surgical procedures – both open and laparoscopic – as well as a variety of techniques.

HPB - We have a renewed focus on bringing greater precision to every aspect of Hepato-Biliary Surgery. From providing training, research and innovative products, we are enabling better outcomes in Hepato-Biliary Surgery.

Thoracic Surgery - We have a renewed focus on bringing greater precision to every aspect of thoracic surgery. From providing training, research and innovative products, we are enabling better outcomes in thoracic surgery.

OSHA† safety guidelines recommend the use of needle-free medical devices to reduce sharp injuries in the surgical setting262

Versatility

Multi-bend blue FlexTip allows for precise placement

Up to 8 hours of effective working time once SURGIFLO® Kit is mixed with Lyophilized human thrombin260

EVITHROM® Thrombin, Topical (Human) for Topical Use Only

Lyophilized Powder for Solution

EVITHROM® is a topical thrombin indicated as an aid to hemostasis whenever oozing blood and minor bleeding from capillaries and small venules is accessible and control of bleeding by standard surgical techniques (such as suture, ligature or cautery) is ineffective or impractical.

EVITHROM® may be used in conjunction with an Absorbable Gelatin Sponge, USP.

Important Safety Information

For topical use only.

Do not inject.

Apply EVITHROM® on the surface of bleeding tissue only.

The amount of EVITHROM® required depends upon the area of tissue to be treated and the method of application. In clinical studies, volumes up to 10 ml were used in conjunction with Absorbable Gelatin Sponge.

Do not use for the treatment of severe or brisk arterial bleeding.

Do not use in individuals known to have anaphylactic or severe systemic reaction to human blood products. Hypersensitivity reactions, including anaphylaxis, may occur.

There is a potential risk of thrombosis if absorbed systemically.

May carry a risk of transmitting infectious agents such as viruses and theoretically, the Creutzfeldt-Jakob disease (CJD) agent, despite manufacturing steps designed to reduce the risk of viral transmission.

The most common adverse reactions during clinical trial (reported in at least 2% of subjects treated with EVITHROM®) were prolonged activated partial thromboplastin time, increased INR, decreased lymphocyte count, prolonged prothrombin time and increased neutrophil count.

None of the patients treated with EVITHROM developed antibodies to human thrombin or to human Factor V/Va. The clinical significance of these findings is unknown.

Share with Friends

By selecting the send button, you agree that an email can be sent from this site to the email address you provided. You also agree that the information you provide will be governed by this site's privacy policy.

Leave this field blank

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Device code translator results

You are now leaving Ethicon.com.

Attention

This site is intended for healthcare professionals in only. Not all products are available in all countries. Please contact your local office for more information. Review our legal notice/terms & conditions and privacy policy